M. Thomas

发表

OP0012 A Phase 3, Randomized, Double-Blind, Active Comparator Study of the Efficacy and Safety of Bow015, A Biosimilar Infliximab, in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses

S. Chandrashekara, J. Kay, K. Bhojani, 2014 .

FRI0203 Golimumab in biologic-naÏve patients with established rheumatoid arthritis (RA), psoriatic arthritis (PSA) or ankylosing spondylitis (AS) - subanalysis from the non-interventional evaluation go-nice

S. Wassenberg, G. Burmester, K. Krüger, 2017 .